PGT Awarded NHS Grant to Fund Pharmacogenetic Study on Patient Response to Breast Cancer Chemotherapy

March 10, 2010

Population Genetics technologies (PGT) Ltd, a privately owned company based in Cambridge, UK today announced that it has been awarded a grant from the National Institute for Health Research (NIHR) as part of the Institute’s Invention for Innovation (i4i) Programme. 

The i4i Programme provides investment in, and improved identification of, promising healthcare technologies in order to accelerate the development of new healthcare products for the 21st century. The i4i programme funds translational research, extending between basic research and pre-clinical trials, or health technology assessments. Read more

“Our technology enables the rapid discovery of gene variants characteristic of a particular disorder or a specific drug response."

Dr. Sydney Brenner – Nobel Laureate and co-founder of Population Genetics Technologies Ltd

Read more.

PGT Awarded NHS Grant to Fund Pharmacogenetic Study

PGT has been awarded a grant from the National Institute for Health Research (NIHR) as part of the Institute’s Invention for Innovation (i4i) Programme.

Read More.